PF-Atlas › Clinical Trials › NCT01882400
Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy
Bisphosphonate treatment · Phase 4
Registry ID
NCT01882400
Phase
Phase 4
Status
Completed
Drug / intervention
Bisphosphonate treatment
Sponsor
Gilles Boire
Start
2001-05
Enrollment
11
Locations
1
About this trial
By supplying an adequate amount of calcium and vitamin D with the addition of weekly bisphosphonate, the investigators will be able to increase bone mass and decrease the incidence of fragility fractures in these children with muscular dystrophy. The investigators think this treatment will also decrease the intensity of pain frequently present in these patients and slow the progression of scoliosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01882400 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.